Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares Outstanding
Ratios

Immunocore Holdings (IMCR) Other Gross PP&E Adjustments (2022 - 2025)

Immunocore Holdings (IMCR) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with $15.6 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 3.81% to $15.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.6 million through Dec 2025, up 3.81% year-over-year, with the annual reading at $15.6 million for FY2025, 3.81% up from the prior year.
  • Other Gross PP&E Adjustments hit $15.6 million in Q4 2025 for Immunocore Holdings, up from -$39.4 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $18.2 million in Q4 2023 to a low of -$39.7 million in Q3 2024.
  • Historically, Other Gross PP&E Adjustments has averaged -$15.7 million across 4 years, with a median of -$32.6 million in 2024.
  • Biggest five-year swings in Other Gross PP&E Adjustments: grew 12.19% in 2023 and later decreased 21.56% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at $16.2 million in 2022, then rose by 12.19% to $18.2 million in 2023, then dropped by 17.64% to $15.0 million in 2024, then increased by 3.81% to $15.6 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for IMCR at $15.6 million in Q4 2025, -$39.4 million in Q3 2025, and -$39.4 million in Q2 2025.